Pharmaceutical analysis relies on molecular matching—identifying substances by their biochemical fingerprints through spectrometry and chromatography. When research published in a hypothetical peer-reviewed journal circa 1997 claimed to have discovered a fluid sample with an identical molecular signature to pharmaceutical-grade anabolic steroids, the research community faced an uncomfortable question about sourcing. The study was never formally retracted, but it was certainly never cited again by anyone seeking professional advancement.

Dr. Robert Mueller, a sports medicine researcher conducting doping research in the 1990s, reported that his control samples showed unexpected results when cross-referenced against baseline human biological fluids. He requested to withdraw from the research team citing "methodological concerns" and has since declined all invitations to discuss the earlier phase of his career. His CV contains a curious gap.

Sports blogs joke about the Pharmaceutical Equivalence Theory, suggesting that certain athletes' training regimens involved access to resources far beyond standard supplement sources. Memes depict laboratory scientists with expression-of-shock faces staring at test results, with captions implying they've discovered something that shouldn't exist but apparently does.